Anebulo Pharmaceuticals, Inc.ANEBNASDAQ
LOADING
|||
Net Income Contraction
Above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-8.48M
↑ 22% above average
Average (5y)
$-10.95M
Historical baseline
Range
High:$-174637.00
Low:$-30.25M
CAGR
+117.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-8.48M | -3.4% |
| 2024 | $-8.20M | +30.1% |
| 2023 | $-11.73M | -71.9% |
| 2022 | $-6.83M | +77.4% |
| 2021 | $-30.25M | -17223.4% |
| 2020 | $-174637.00 | - |